Tags

Type your tag names separated by a space and hit enter

GnRH agonist versus GnRH antagonist in ovarian stimulation: the role of endometrial receptivity.
Fertil Steril. 2008 Oct; 90(4):1294-6.FS

Abstract

To examine whether the choice of the GnRH analogues used during controlled ovarian hyperstimulation (COH), may influence endometrial receptivity, we studied 712 IVF cycles, in patients undergoing COH with GnRH agonist or antagonist and with the transfer of at least one top-quality embryo. The GnRH agonist group showed significantly higher endometrial thickness and higher pregnancy rate, suggestive of a higher endometrial receptivity, compared with the GnRH antagonist group.

Authors+Show Affiliations

Department of Obstetrics and Gynecology, Barzilai Medical Center, Ashkelon, Israel. raoulo@barzi.health.gov.ilNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Controlled Clinical Trial
Journal Article

Language

eng

PubMed ID

18178197

Citation

Orvieto, Raoul, et al. "GnRH Agonist Versus GnRH Antagonist in Ovarian Stimulation: the Role of Endometrial Receptivity." Fertility and Sterility, vol. 90, no. 4, 2008, pp. 1294-6.
Orvieto R, Meltzer S, Rabinson J, et al. GnRH agonist versus GnRH antagonist in ovarian stimulation: the role of endometrial receptivity. Fertil Steril. 2008;90(4):1294-6.
Orvieto, R., Meltzer, S., Rabinson, J., Zohav, E., Anteby, E. Y., & Nahum, R. (2008). GnRH agonist versus GnRH antagonist in ovarian stimulation: the role of endometrial receptivity. Fertility and Sterility, 90(4), 1294-6. https://doi.org/10.1016/j.fertnstert.2007.10.022
Orvieto R, et al. GnRH Agonist Versus GnRH Antagonist in Ovarian Stimulation: the Role of Endometrial Receptivity. Fertil Steril. 2008;90(4):1294-6. PubMed PMID: 18178197.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - GnRH agonist versus GnRH antagonist in ovarian stimulation: the role of endometrial receptivity. AU - Orvieto,Raoul, AU - Meltzer,Simion, AU - Rabinson,Jacob, AU - Zohav,Efraim, AU - Anteby,Eyal Y, AU - Nahum,Ravit, Y1 - 2008/01/07/ PY - 2007/09/28/received PY - 2007/10/08/revised PY - 2007/10/08/accepted PY - 2008/1/8/pubmed PY - 2008/11/15/medline PY - 2008/1/8/entrez SP - 1294 EP - 6 JF - Fertility and sterility JO - Fertil Steril VL - 90 IS - 4 N2 - To examine whether the choice of the GnRH analogues used during controlled ovarian hyperstimulation (COH), may influence endometrial receptivity, we studied 712 IVF cycles, in patients undergoing COH with GnRH agonist or antagonist and with the transfer of at least one top-quality embryo. The GnRH agonist group showed significantly higher endometrial thickness and higher pregnancy rate, suggestive of a higher endometrial receptivity, compared with the GnRH antagonist group. SN - 1556-5653 UR - https://www.unboundmedicine.com/medline/citation/18178197/GnRH_agonist_versus_GnRH_antagonist_in_ovarian_stimulation:_the_role_of_endometrial_receptivity_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0015-0282(07)03875-7 DB - PRIME DP - Unbound Medicine ER -